Neocortical hyperexcitability in a genetic model of absence seizures and its reduction by levetiracetam

Epilepsia

Volumn 47, Issue 7, 2006, Pages 1144-1152

  D'Arcangelo, Giovanna ^a   D'Antuono, Margherita ^a   Tancredi, Virginia ^a   Avoli, Massimo ^b,c,d  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Absence epilepsy; Intrinsic optical signals; Levetiracetam

Indexed keywords

ENFLURANE; ETIRACETAM; STAINLESS STEEL;

ABSENCE; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTRODE; ELECTROSTIMULATION; GENETIC MODEL; ILLUMINATION; IMAGE ENHANCEMENT; NEOCORTEX; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SOMATOSENSORY CORTEX; STATISTICAL SIGNIFICANCE;

4-AMINOPYRIDINE; AGE FACTORS; ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; EPILEPSY, ABSENCE; IMAGE ENHANCEMENT; MODELS, GENETIC; NEOCORTEX; OSCILLOMETRY; PIRACETAM; RATS; RATS, INBRED STRAINS; RATS, WISTAR; SIGNAL PROCESSING, COMPUTER-ASSISTED; SOMATOSENSORY CORTEX; VIDEOTAPE RECORDING;

EID: 33746123391     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2006.00588.x     Document Type: Article

References (61)

1. Panayiotopoulos CP. Typical absence seizures and their treatment. Arch Dis Child 1999;81:351-5.
2. Avoli M, Rogawsk MA, Avanzini G. Generalized epileptic disorders: an update. Epilepsia 2001;42:445-57.
3. Crunelli V, Leresche N. Childhood absence epilepsy: genes, channels, neurons and networks. Nat Rev Neurosci 2002;3:371-82.
4. Vergnes M, Marescaux C, Depaulis A, et al. Spontaneous spike-wave discharges in Wistar rats: a model of genetic generalized convulsive epilepsy. In: Avoli M, Gloor P, Kostopoulos G, et al., eds. Generalized epilepsy: neurobiological approaches. Boston: Birkhäuser, 1990:238-53.
5. van Luijtelaar ELJM, Coenen AML. Two types of electrocortical paroxysms in an inbred strain of rats. Neurosci Lett 1986;70:393-7.
6. Coenen AML, van Luijtelaar ELJM. Genetic animal models for absence epilepsy: a review of the WAG/Rij strain of rats. Behav Genet 2003;33:635-55.
7. Lennox WG, Lennox MA. Epilepsy and related disorders. Boston: Little Brown, 1960.
8. Metrakos K, Metrakos JD. Genetics of convulsive disorders, II: genetic and electroencephalographic studies in centrencephalic epilepsy. Neurology 1961;11:464-83.
9. Avoli M, Gloor P, Kostopoulos G, et al. An analysis of penicillin-induced generalized spike and wave discharges using simultaneous recordings of cortical and thalamic single neurons. J Neurophysiol 1983;50:819-37.
10. Neckelmann D, Amzica F, Steriade M. Spike-wave complexes and fast components of cortically generated seizures, III: synchronizing mechanisms. J Neurophysiol 1998;80:1480-94.
11. Steriade M, Amzica F, Neckelmann D, et al. Spike-wave complexes and fast components of cortically generated seizures, II: extra- and intracellular patterns. J Neurophysiol 1998;80:1456-79.
12. Timofeev I, Grenier F, Steriade M. Spike-wave complexes and fast components of cortically generated seizures, IV: paroxysmal fast runs in cortical and thalamic neurons. J Neurophysiol 1998;80:1495-513.
13. Steriade M, Contreras D. Spike-wave complexes and fast components of cortically generated seizures, I: role of neocortex and thalamus. J Neurophysiol 1998;80:1439-55.
14. Charpier S, Leresche N, Deniau JM, et al. On the putative contribution of GABA(B) receptors to the electrical events occurring during spontaneous spike and wave discharges. Neuropharmacology 1999;38:1699-706.
15. Pinault D. Cellular interactions in the rat somatosensory thalamocortical system during normal and epileptic 5-9 Hz oscillations. J Physiol (Lond) 2003;552:881-905.
16. Seidenbecher T, Staak R, Pape HC. Relations between cortical and thalamic cellular activities during absence seizures in rats. Eur J Neurosci 1998;10:1103-12.
17. Vergnes M, Boehrer A, Nehlig A. Developmental characteristics of picrotoxin-induced convulsions in rats with genetic absence epilepsy. Exp Neurol 2003;184:549-51.
18. Meeren HK, Pijn JP, van Luijtelaar EL, et al. Cortical focus drives widespread corticothalamic networks during spontaneous absence seizures in rats. J Neurosci 2002;22L:1480-95.
19. Nersesyan H, Hyder F, Rothman DL, et al. Dynamic fMRI and EEG recordings during spike-wave seizures and generalized tonic-clonic seizures in WAG/Rij rats. J Cereb Blood Flow Metab 2004;24:589-99.
20. Manning JP, Richards DA, Leresche N, et al. Cortical-area specific block of genetically determined absence seizures by ethosuximide. Neuroscience 2003;123:5-9.
21. D'Arcangelo G, D'Antuono M, Biagini G, et al. Thalamocortical oscillations in a genetic model of absence seizures. Eur J Neurosci 2002;16:2383-93.
22. Coenen AML, van Luijtelaar ELJM. The WAG/Rij rat model for absence epilepsy: age and sex factors. Epilepsy Res 1987;1:97-301.
23. MacVicar B, Hochman D. Imaging of synaptically evoked intrinsic optical signals in hippocampal slices. J Neurosci 1991;11:1458-69.
24. Andrew RD, MacVicar B. Imaging cell volume changes and neuronal excitation in the hippocampal slice. Neuroscience 1994;62:371-83.
25. Hochman D, Baraban S, Owens J, et al. Dissociation of synchronization and excitability in furosemide blockade of epileptiform activity. Science 1995;270:99-102.
26. Dodt HU, D'Arcangelo G, Pestel E, et al. The spread of excitation in neocortical columns visualized with infrared-darkfield videomicroscopy. Neuroreport 1996;7:1553-8.
27. Buchheim K, Schuchmann S, Siegmund H, et al. Intrinsic optical signal measurements reveal characteristic features during different forms of spontaneous neuronal hyperactivity associated with ECS shrinkage in vitro. Eur J Neurosci 1999;11:1877-82.
28. Klitgaard H. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs? Epilepsia 2001;42(suppl 4):13-8.
29. Marson AG, Hutton JL, Leach JP, et al. Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review. Epilepsy Res 2001;46:259-70.
30. Leppik IE. Levetiracetam: clinical use. In: Levy RH, Mattson RH, Meldrum BS, et al., eds. Antiepileptic drugs. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2002:433-41.
31. Sullivan JE, Dlugos DJ. Idiopathic generalized epilepsy. Curr Treat Options Neurol 2004;6:231-42.
32. Drinkenburg WH, van Luijtelaar EL, van Schaijk WJ, et al. Aberrant transients in the EEG of epileptic rats: a spectral analytical approach. Physiol Behav 1993;54:779-83.
33. Midzianovskaia IS, Kuznetsova GD, Coenen AM, et al. Electrophysiological and pharmacological characteristics of two types of spike-wave discharges in WAG/Rij rats. Brain Res 2001;911:62-70.
34. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 4th ed. San Diego: Academic Press, 1998.
35. D'Arcangelo G, Tancredi V, Avoli M. Intrinsic optical signals and electrographic seizures in the rat limbic system. Neurobiol Dis 2001;8:993-1005.
36. D'Arcangelo G, Tancredi V, Onofri F, et al. Interleukin-6 inhibits neurotransmitter release and the spread of excitation in the rat cerebral cortex. Eur J Neurosci 2000;12:1241-52.
37. Margineanu DG, Klitgaard H. Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs. Pharmacol Res 2000;42:281-5.
38. Potier B, Poindessous-Jazat F, Dutar P, Billard JM. NMDA receptor activation in the aged rat hippocampus. Exp Gerontol 2000;35:1185-99.
39. Segovia G, Porras A, Del Arco A, et al. Glutamatergic neurotransmission in aging: a critical perspective. Mech Ageing Dev 2001;122:1-29.
40. A receptor subunit mRNA levels in Fisher rats. Mol Brain Res 1992;14:71-8.
41. Post-Munson DJ, Lum-Ragan JT, Mahle CD, et al. Reduced bicuculline response and GABAA agonist binding in aged rat hippocampus. Neurobiol Aging 1994;15:629-33.
42. Poe BH, Linville C, Brunso-Bechtold J. Age-related decline of presumptive inhibitory synapses in the sensorimotor cortex as revealed by the physical disector. J Comp Neurol 2001;439:65-72.
43. Duan H, Wearne SL, Rocher AB, et al. Age-related dendritic and spine changes in corticocortical projecting neurons in macaque monkeys. Cereb Cortex 2003;19:950-61.
44. Chen KS, Masliah E, Mallory M, et al. Synaptic loss in cognitively impaired aged rats is ameliorated by chronic human nerve growth factor infusion. Neuroscience 1995;68:19-27.
45. Wong TP, Campbell PM, Ribeiro-da-Silva A, et al. Synaptic numbers across cortical laminae and cognitive performance of the rat during ageing. Neuroscience 1998;84:403-12.
46. Luhmann HJ, Mittmann T, van Luijtelaar G, et al. Impairment of intracortical GABAergic inhibition in a rat model of absence epilepsy. Epilepsy Res 1995;22:43-51.
47. Albowitz B, Kuhnt U. Epileptiform activity in the guinea-pig neocortical slice spreads preferentially along supragranular layers: recordings with voltage-sensitive dyes. Eur J Neurosci 1995;7:1273-84.
48. Alefeld M, Sutor B, Luhmann HJ. Pattern and pharmacology of propagating epileptiform activity in mouse cerebral cortex. Exp Neurol 1998;153:113-22.
49. Connors BW. Initiation of synchronized neuronal bursting in neocortex. Nature 1984;310:685-7.
50. Chagnac-Amitai Y, Connors BW. Synchronized excitation and inhibition driven by intrinsically bursting neurons in neocortex. J Neurophysiol 1989;62:1149-62.
51. Buckle PJ, Haas HL. Enhancement of synaptic transmission by 4-aminopyridine in hippocampal slices of the rat. J Physiol 1982;326:109-22.
52. Perreault P, Avoli M. Effects of low concentrations of 4-aminopyridine on CA1 pyramidal cells of the hippocampus. J Neurophysiol 1989;61:953-70.
53. Lynch BA, Lambeng N, Nocka K, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA 2004;101:9861-6.
54. Margineanu D-G, Klitgaard H. Levetiracetam: mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS, et al., eds. Antiepileptic drugs. 5th ed. Baltimore: Lippincott Williams & Wilkins, 2002:19-427.
55. - exchange of adult hippocampal CA3 neurons from guinea-pigs. Br J Pharmacol 2004;142:1073-80.
56. Birnstiel S, Wülfert E, Beck SG. Levetiracetam (ucbL059) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission. Naunyn Schmiedebergs Arch Pharmacol 1997;356:611-8.
57. Gorji A, Hohling JM, Madeja M, et al. Effect of levetiracetam on epileptiform discharges in human neocortical slices. Epilepsia 2000;43:1480-7.
58. Gower AJ, Hirsch E, Boehrer A, et al. Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy Res 1995;22:207-13.
59. Bouwman BM, van Rijn CM. Effects of levetiracetam on spike and wave discharges in WAG/Rij rats. Seizure 2003;13:591-4.
60. Cohen J. Levetiracetam monotherapy for primary generalised epilepsy. Seizure 2003;12:150-3.
61. Weber S, Beran RG. A pilot study of compassionate use of levetiracetam in patients with generalised epilepsy. J Clin Neurosci 2004;11:728-31.